Research map: Protecting the gut microbiome when treating bloodstream infections: the price of anaerobic coverage

Back to the article

Papers in this map

  1. Extensive impact of non-antibiotic drugs on human gut bacteria · Lisa A. Maier · 2018 · 2016 citations · Cited by this paper
  2. A Nonsporulating Sinonasal Culprit · 2026 · Related
  3. Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017 · Jean‐Louis Vincent · 2020 · 1073 citations · Cited by this paper
  4. Persistence of Serum Bactericidal Antibody in the First 2-Years After Immunization with Pentavalent Meningococcal ACWYX Vaccine in Malian Infants and Toddlers · 2026 · Related
  5. The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages · Julie Schulthess · 2019 · 1055 citations · Cited by this paper
  6. Antiviral Effect, Safety, and Tolerability of Oral VH4011499 (VH-499), a New HIV-1 Capsid Inhibitor: Proof-of-Concept Trial · 2026 · Related
  7. Interaction between drugs and the gut microbiome · Rinse Karel Weersma · 2020 · 972 citations · Cited by this paper
  8. Fowling in the Marshes · 2026 · Related
  9. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia · Tim J. Schuijt · 2015 · 860 citations · Cited by this paper
  10. Subgroup Analysis of Pooled Phase 3 Efficacy Data From Two Randomized Trials of Gepotidacin Versus Nitrofurantoin in Uncomplicated Urinary Tract Infections (EAGLE-2 and EAGLE-3) Including Participants With Uropathogens Not-Susceptible to Nitrofurantoin · 2026 · Related
  11. Gut microbiota-derived short-chain fatty acids and their role in human health and disease · Indrani Mukhopadhya · 2025 · 477 citations · Cited by this paper
  12. Vaccines, Bias, and the Perils of Non-peer-reviewed Studies: Fueling Misinformation and Vaccine Hesitancy · 2026 · Related
  13. Extreme Dysbiosis of the Microbiome in Critical Illness · Daniel T. McDonald · 2016 · 442 citations · Cited by this paper
  14. Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial · 2026 · Related
  15. The gut microbiome’s role in the development, maintenance, and outcomes of sepsis · Max W. Adelman · 2020 · 348 citations · Cited by this paper
  16. Challenging Weight-Tiered Antibiotic Prophylaxis in Obese Patients Undergoing Colorectal Surgery Using Computed Tomography-Derived Body Composition · 2026 · Related
  17. Hospitalization Type and Subsequent Severe Sepsis · Hallie C. Prescott · 2015 · 188 citations · Cited by this paper
  18. Detection-Dependent Classification of Valve Strands: How Much Does Imaging Intensity Drive the “Noninfective Endocarditis” Diagnosis? · 2026 · Related
  19. Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection · Edward T. Qian · 2023 · 149 citations · Cited by this paper
  20. In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes · Rishi Chanderraj · 2022 · 146 citations · Cited by this paper
  21. Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections · The BALANCE Investigators · 2024 · 146 citations · Cited by this paper
  22. Disruptions of Anaerobic Gut Bacteria Are Associated with Stroke and Post-stroke Infection: a Prospective Case–Control Study · Bastiaan W. Haak · 2020 · 144 citations · Cited by this paper
  23. Executive Summary: Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026 · Hallie C. Prescott · 2026 · 124 citations · Cited by this paper
  24. Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens · Charles Burdet · 2019 · 73 citations · Cited by this paper
  25. Mortality of Patients With Sepsis Administered Piperacillin-Tazobactam vs Cefepime · Rishi Chanderraj · 2024 · 70 citations · Cited by this paper
  26. Association between butyrate-producing gut bacteria and the risk of infectious disease hospitalisation: results from two observational, population-based microbiome studies · Robert F. J. Kullberg · 2024 · 56 citations · Cited by this paper
  27. Empirical antibiotic therapy for sepsis: save the anaerobic microbiota · Robert F. J. Kullberg · 2024 · 55 citations · Cited by this paper
  28. Empiric anti-anaerobic antibiotics are associated with adverse clinical outcomes in emergency department patients · Robert F. J. Kullberg · 2023 · 29 citations · Cited by this paper
  29. Identification of medication–microbiome interactions that affect gut infection · Aman Kumar · 2025 · 29 citations · Cited by this paper
  30. Effect of step-down therapy of ceftriaxone plus loracarbef versus parenteral therapy of ceftriaxone on the intestinal microflora in patients with community-acquired pneumonia · F. Vogel · 2001 · 18 citations · Cited by this paper
  31. Dynamics of the gut and lung microbiota in severe infections: from observational studies to therapeutic strategies · Duveke P. E. de Gaay Fortman · 2026 · 5 citations · Cited by this paper
  32. The impact of different antimicrobial exposures on the gut microbiome in the ARMORD observational study · Leon Peto · 2025 · 2 citations · Cited by this paper
  33. Association of anti-anaerobic antibiotics with mortality and the gut microbiome: a sub-study of the BALANCE randomized clinical trial · Eric Armstrong · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)